Prepare for your visit

Isabel Perez

Bolingbrook, IL

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$41.13

in general payments reported to CMS, 2019-2025 · $23.98 in 2025

The $23.98 reported for 2025 was less than what a typical provider received nationally.

Who reported paying

General payments only, top 2 by amount.

Neurocrine Biosciences, INC. $23.98
Acadia Pharmaceuticals INC $17.15

Drugs and devices associated with these payments

Ingrezza

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

I saw Isabel Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11433352/isabel-perez